alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 62, Number 202 (Monday, October 20, 1997)]
[Notices]
[Page 54481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27717]


=======================================================================
-----------------------------------------------------------------------

NATIONAL EDUCATION GOALS PANEL


Notice of a Meeting

AGENCY: National Education Goals Panel.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice sets forth the date and location of a forthcoming 
meeting of the National Education Goals Panel. This notice also 
describes the functions of the Panel.

DATES AND TIMES: Wednesday, November 5, 1997 from 9:00 a.m. to 11:00 
a.m.

ADDRESSES: Hyatt Regency Washington on Capitol Hill, 400 New Jersey 
Avenue, NW, Columbia Ballroom B, Washington, DC 20001.

FOR FURTHER INFORMATION:
Ken Nelson, Executive Director, 1255 22nd Street, NW, Suite 502, 
Washington, DC 20037. Telephone: (202) 724-0015.

SUMMARY: National Education Goals Panel was established to monitor, 
measure and report state and national progress toward achieving the 
eight National Education Goals, and report to the states and the Nation 
on that progress.

AGENDA ITEMS: The meeting of the Panel is open to the public. The first 
item on the agenda is the release of the 1997 National Education Goals 
Report. The theme of this year's report is ``Mathematics and Science 
Achievement for the 21st Century.'' The report highlights student 
achievement in math and science, with a special emphasis on the Third 
International Math and Science Study (TIMSS). It provides national data 
on 26 indicators and state data on 33 indicators for the eight National 
Education Goals.
The second item on the agenda will have the Panel receive and discuss 
the policy recommendations of its Goals 3/4/5 Standards Implementation 
Advisory Group.

Dated: October 15, 1997.
Ken Nelson,
Executive Director, National Education Goals Panel.
[FR Doc. 97-27717 Filed 10-17-97; 8:45 am]
BILLING CODE 4010-01-M
#### WASHINGTON FEDERAL SAVINGS & LOAN ASSOCIATION OF MIAMI BEACH, Relator, v. Fred O. DICKINSON, Jr., as Comptroller and Banking Commissioner of the State of Florida, Respondent.

No. 0-303.

District Court of Appeal of Florida, First District.

March 4, 1971.

McClure, Wigginton, McClure & Cul-pepper, Tallahassee, and Katz & Salmon, Miami Beach, for Relator.

V. Carroll Webb, and Larry Levy, Tallahassee, for respondent.

PER CURIAM.

Upon consideration of Relator’s suggestion for writ of prohibition, this Court issued rule nisi, heard arguments upon the merits and fully reviewed the cause. We conclude that Relator has not demonstrated a right to the relief prayed, and we, therefore, deny the suggestion and discharge the rule nisi.

CARROLL, DONALD K., Acting C. J., RAWLS and SPECTOR, JJ., concur.
#### Alan LIVINGSTON, Appellant, v. The STATE of Florida, Appellee.

No. 77-190.

District Court of Appeal of Florida, Third District.

July 11, 1978.

Bennett H. Brummer, Public Defender and Kurt Marmar, Asst. Public Defender, for appellant.

Robert L. Shevin, Atty. Gen. and Anthony C. Musto, Asst. Atty. Gen., for appellee.

*481Before HENDRY, J., GOMEZ, HELIO, Associate Judge, and CHARLES CARROLL (Ret.), Associate Judge.

PER CURIAM.

Affirmed. See *State v. Jones,*204 So.2d 515 (Fla.1967); *Castle v. State,*305 So.2d 794 (Fla. 4th DCA 1974), affirmed at 330 So.2d 10 (Fla.1976).
| 1)   | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|----------------|-----------------------------------------------------------------------------------------------------------------------|

| 2)   | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date: September 22, 2011 | By:    | /s/ James Kedrowski                                   |   |
|--------------------------|--------|-------------------------------------------------------|--------|
|                     |   | James Kedrowski                                       |
|                     |   | Interim Chief Executive Officer and Director          |
|                     |   |
|                     |   |
|                     |   |
|                     | By:    | /s/ Michael Kalb                                      |   |
|                     |   | Michael Kalb                                          |
|                     |   | Group Vice President, Interim Chief Financial Officer |
<PAGE>

                                                                    Exhibit 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the Annual Report of Key Technology, Inc. (the
"Company") on Form 10-K for the period ending September 30, 2002 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Thomas C. Madsen, Chief Executive Officer of the Company, certify pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

          (1) The Report fully complies with the requirements of Section 13(a)
or 15(d) of the Securities Exchange Act of 1934; and

          (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/  Thomas C. Madsen
---------------------
Thomas C. Madsen
Chief Executive Officer
December 19, 2002
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 30 Introduced in Senate (IS)]

<DOC>

118th CONGRESS
  1st Session
                                 S. 30

  To authorize major medical facility projects for the Department of 
     Veterans Affairs for fiscal year 2023, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

             January 24 (legislative day, January 3), 2023

 Mr. Tester (for himself and Mr. Moran) introduced the following bill; 
which was read twice and referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
  To authorize major medical facility projects for the Department of 
     Veterans Affairs for fiscal year 2023, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Fiscal Year 2023 Veterans Affairs 
Major Medical Facility Authorization Act''.

SEC. 2. AUTHORIZATION OF MAJOR MEDICAL FACILITY PROJECTS OF DEPARTMENT 
              OF VETERANS AFFAIRS FOR FISCAL YEAR 2023.

    (a) In General.--The Secretary of Veterans Affairs may carry out 
the following major medical facility projects in fiscal year 2023 at 
the locations specified and in an amount for each project not to exceed 
the amount specified for such location:
            (1) Construction of a community-based outpatient clinic and 
        national cemetery in Alameda, California, in an amount not to 
        exceed $395,000,000.
            (2) Construction of a community living center and 
        renovation of domiciliary and outpatient facilities in 
        Canandaigua, New York, in an amount not to exceed $506,400,000.
            (3) Construction of a new health care center in El Paso, 
        Texas, in an amount not to exceed $700,000,000.
            (4) Seismic upgrade and specialty care improvements in Fort 
        Harrison, Montana, in an amount not to exceed $88,600,000.
            (5) Realignment and closure of the Livermore campus in 
        Livermore, California, in an amount not to exceed $490,000,000.
            (6) Construction of a new medical facility in Louisville, 
        Kentucky, in an amount not to exceed $1,013,000,000.
            (7) Seismic retrofit and renovation of buildings 100 and 
        101 in Portland, Oregon, in an amount not to exceed 
        $523,000,000.
            (8) Replacement of the VA Sierra Nevada Health Care System 
        Medical Center in Reno, Nevada, in an amount not to exceed 
        $223,800,000.
    (b) Authorization of Appropriations.--There is authorized to be 
appropriated to the Secretary of Veterans Affairs for fiscal year 2023 
or the year in which funds are appropriated for the Construction, Major 
Projects account, $3,939,800,000 for the projects authorized in 
subsection (a).
                                 <all>
```
#### Raymond H. GRANDJEAN, Appellant, v. Lola Mae BENNETT, Appellee.

No. 69-344.

District Court of Appeal of Florida. Second District.

Nov. 6, 1969.

Appeal dismissed.
In the

Court of Appeals

Second Appellate District of Texas

at Fort Worth

No. 02-17-00340-CR

ANTONO MASADA JAMES RAGSDALE,

Appellant

V.

THE STATE OF TEXAS

§

§

§

§

§

On Appeal from the 213th District 

Court

of Tarrant County (1457150D)

June 13, 2019

Opinion by Justice Kerr

(nfp)

JUDGMENT

This court has considered the record on appeal in this case and holds that there 

was no error in the trial court’s judgment. It is ordered that the judgment of the trial 

court is affirmed.

SECOND DISTRICT COURT OF APPEALS 

By _/s/ Elizabeth Kerr__________________

 Justice Elizabeth Kerr
#### STATE of Florida, Petitioner, v. Thomas Allen DONOHOE, Respondent.

No. 77-2470.

District Court of Appeal of Florida, Fourth District.

May 9, 1978.

Rehearing Denied June 28, 1978.

Robert L. Shevin, Atty. Gen., Tallahassee, and Basil S. Diamond, Asst. Atty. Gen., West Palm Beach, for petitioner.

Ned N. Julian, Jr. of Stenstrom, Davis & McIntosh, Sanford, for respondent.

PER CURIAM.

Petition for Writ of Common Law Certio-rari is hereby DENIED.

CROSS, LETTS and MOORE, JJ., concur.
Exhibit 21.1
 SUBSIDIARIES
  Jurisdiction of Incorporation orName of Subsidiary
    
    OrganizationAlternative Benefit Management, Inc.
    
    NevadaAmerican National County Mutual Insurance Company
    
    TexasAmerican National General Insurance Company
    
    MissouriAmerican National Insurance Service Company
    
    MissouriAmerican National Investment Accounts, Inc.
    
    MarylandAmerican National Life Holdings, Inc.
    
    NevadaAmerican National Life Insurance Company of Texas
    
    TexasAmerican National Life Insurance Company of New York
    
    New YorkAmerican National Lloyds Insurance Company
    
    TexasAmerican National of Delaware Corporation
    
    DelawareAmerican National Property & Casualty Holdings, Inc.
    
    DelawareAmerican National Property and Casualty Company
    
    MissouriAN Stonebriar, Ltd.
    
    TexasAN/CAN Investments, Inc.
    
    CanadaANDV 97, Inc.
    
    TexasANH20, Inc.
    
    TexasANIND TX, Inc.
    
    TexasANPAC General Agency of Texas
    
    TexasANPAC Lloyds Insurance Management, Inc.
    
    TexasANPAC Louisiana Insurance Company
    
    LouisianaANPIN, L.P.
    
    TexasANREINV, Inc.
    
    TexasANREM Corporation
    
    TexasANTAC, Inc.
    
    NevadaComprehensive Investment Services, Inc.
    
    NevadaEagle 99, Inc.
    
    NevadaEagle AN, L.P.
    
    TexasEagle Ind., L.P.
    
    TexasFarm Family Casualty Insurance Company
    
    New YorkFarm Family Financial Services, Inc.
    
    New YorkFarm Family Life Insurance Company
    
    New YorkGalveston Island Water Park, L.P.
    
    TexasGarden State Life Insurance Company
    
    TexasLawyers Title of Galveston
    
    TexasPacific Property and Casualty Company
    
    CaliforniaPCO Battery Brooke Parkway, L.P.
    
    VirginiaPCO Carolina Pines, L.P.
    
    South CarolinaPCO Corporate Drive Limited Partnership
    
    North CarolinaPCO Jenkins Brothers Road, L.P.
    
    South CarolinaPCO Kent Drive, L.P.
    
    GeorgiaPCO Nashville, L.P.
    
    TennesseePCO Northfork, L.P.
    
    TennesseePCO Omnicron Court, L.P.
    
    KentuckyPCO Watkins Road, L.P.
    
    North CarolinaPreston 121 Partners, Ltd.
    
    TexasR.A.A.B. of W. Va., Inc.
    
    West VirginiaRural Agency and Brokerage of New Hampshire, Inc.
    
    New HampshireRural Agency and Brokerage, Inc.
    
    New YorkRural Insurance Agency and Brokerage of Massachusetts, Inc.
    
    MassachusettsSecurities Management and Research, Inc.
    
    FloridaSM&R Investments, Inc.
    
    MarylandSouth Shore Harbour Development, Ltd.
    
    TexasStandard Life and Accident Insurance Company
    
    TexasStandard Plus, Inc.
    
    TexasUnited Farm Family Insurance Company
    
    New York
 
    
    In addition to the entities shown in this chart, American National Insurance Company owns a direct or
indirect interest in certain joint ventures and limited partnerships. Such ownership is primarily in connection
with real estate investments. In addition, American National Insurance Company owns several shell
companies, which are currently inactive.
Exhibit

10.1




 




STRAIGHT NOTE




 








	

  $850,000


  	

   


  	

  South El Monte,

  California


  	

   


  	

  October 7, 2002


  










 




For value received, Lee Pharmaceuticals promises to

pay Mark DiSalvo or order, at South El Monte, California the sum of EIGHT

HUNDRED FIFTY THOUSAND DOLLARS, with interest from October 7, 2002, on unpaid

principal at the rate of twenty (20) per cent per annum.  Accrued interest each month will be added to

the principal balance.  Thus, the principal

at the beginning of each month will include the original principal ($550,000)

plus accrued interest.  In May/June 2003

an additional $300,000 will be disbursed to complete the acquisition.  This will continue until June 30, 2003.  Commencing August 15, 2002, monthly payments

will be $30,000.  Interest shall be

calculated on the basis of the unpaid principal balance daily, based on a

365-day year, actual day month and payable monthly.  Principal and interest shall be payable in lawful money of the

United States.  If action were

instituted on this note, I promise to pay such sum as the Court may fix as

attorney’s fees.  This note is secured

by the trademark on the product brand Tronolane®.




 




 




	

  OCTOBER 7, 2002


  	

   


  	

  /s/ RONALD G. LEE


  	

   


  
	

  Date


  	

   


  	

  Lee Pharmaceuticals - Ronald G. Lee


  	

   


  





 




 




	

  OCTOBER 7, 2002


  	

   


  	

  /s/ MICHAEL L. AGRESTI


  	

   


  
	

  Date


  	

   


  	

  Lee Pharmaceuticals - Michael L. Agresti
**Exhibit 23.1**

Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm 

We have issued our report datedDecember 11, 2006, accompanying the consolidated financial statements included in the Annual Report of Key Technology, Inc. on Form 10-K for the year ended September 30, 2006. We hereby consent to the incorporation by referenceof said report in the Registration Statements of Key Technology, Inc. on Form S-8 (File Nos. 33-71108, 333-50130, 333-128512, and 333-2396). 

/s/ GRANTTHORNTON LLP 

Seattle, Washington 

December 13, 2006
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in Local Rule

47.5.4.

UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

_____________________

No. 96-50555

Summary Calendar

_____________________

ROBERT BOHLER,

Plaintiff-Appellant,

versus

EXPRESS TECH, INC.,

Defendant-Appellee.

_________________________________________________________________

Appeal from the United States District Court

for the Western District of Texas

(SA-95-CV-770)

_________________________________________________________________

January 23, 1997

Before SMITH, DUHÉ, and BARKSDALE, Circuit Judges.

PER CURIAM:*

Robert Bohler appeals the summary judgment awarded Express

Tech, Inc., his former employer, on Bohler’s claims under the

Family Medical Leave Act (FMLA), 29 U.S.C. §§ 2601-2654; the

Americans with Disabilities Act (ADA), 42 U.S.C. §§ 12101-12213;

and the Rehabilitation Act of 1973, 29 U.S.C. §§ 791-793.

The FMLA claim fails because Bohler presented insufficient

evidence that Express Tech employed over 50 employees, as required

by that act. See 29 U.S.C. § 2611(2)(B)(ii). His ADA claim fails
- 2 -

because, assuming arguendo that his diabetic condition is a

“disability”, he presented no evidence that he requested (and was

denied) reasonable accommodation. See 42 U.S.C. § 12112(b)(5)(A).

Finally, as conceded by Bohler in his appellate brief, the

Rehabilitation Act claim fails because Express Tech is a federal

contractor, and the that Act does not provide a private cause of

action for employees. See 29 U.S.C. § 793(b). 

That summary judgment was proper is reflected in the district

court’s 14 June 1996 Order Granting Summary Judgment. Bohler

claims also that the district court abused its discretion in

denying his motion to withdraw deemed admissions. See FED R. CIV.

P. 36. (Bohler never responded to Express-Tech’s request for

admissions, which were properly deemed admitted. FED. R. CIV. P.

36(a).) The court determined in its summary judgment ruling that

Bohler had failed to show either good cause to reopen discovery or

a lack of prejudice to Express-Tech. FED. R. CIV. P. 36(b). We

find no abuse of discretion in this ruling.

AFFIRMED
#### Wynell LIPHAM, Appellant, v. STATE of Florida, Appellee.

No. 68-508.

District Court of Appeal of Florida. Second District.

July 2, 1969.

Rehearing Denied Aug. 15, 1969.

PER CURIAM.

Affirmed.
#### The FIRST BANK AND TRUST COMPANY OF JACKSONVILLE, a corporation, as administrator of the Estate of George H. Weiland, deceased, et al., Appellant, v. DUVAL DEVELOPMENT COMPANY, a corporation, Appellee.

No. L-311.

District Court of Appeal of Florida. First District.

Dec. 9, 1969.

Rehearing Denied Jan. 14, 1970.

*300George A. Stelogeannis, Jacksonville, for Greene, Greene, Kennelly & Stockton, for appellant.

Bryant, Freeman, Richardson & Watson, Jacksonville, for appellee.

PER CURIAM.

This appeal questions the correctness of a summary judgment rendered in favor of the appellee landlord in a suit for damages for breach of a lease agreement.

A careful examination of the record on appeal and the briefs filed herein conclusively establishes the absence of any genuine triable issue of material fact and that appellee was entitled to judgment as a matter of law. The judgment appealed is accordingly affirmed. Florida State Turnpike Authority v. Michael Baker, Jr., Inc., 156 So.2d 198 (Fla.App.1963).

JOHNSON, C. J., and RAWLS and SPECTOR, JJ., concur.
[Federal Register Volume 62, Number 201 (Friday, October 17, 1997)]
[Notices]
[Pages 54118-54119]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-27531]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Advisory Committee for Pharmaceutical Science; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.


[[Page 54119]]


ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Advisory Committee for Pharmaceutical Science.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA regulatory issues.
    Date and Time: The meeting will be held on December 11 and 12, 
1997, 8:30 a.m. to 5:30 p.m.
    Location: Quality Hotel, Maryland Room, 8727 Colesville Rd., Silver 
Spring, MD.
    Contact Person: Kimberly Littleton Topper, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-443-5455, (FedEx--Chapman Bldg., 
801 Thompson Ave., rm. 200, Rockville, MD 20852), or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12539. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: On December 11, 1997, the committee will discuss the 
Biopharmaceutics Classification System, topicals-dermatological drug 
products, and Narrow Therapeutic Index Drugs and relevance to product 
quality testing. On December 12, 1997, the committee will discuss the 
drug-drug interaction studies, and bioequivalence studies that fail to 
meet established confidence intervals.
    Procedure: Interested persons may present data, information, or 
views, orally, or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by December 1, 
1997. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. on December 11, 1997, and between 
approximately 1:30 p.m. and 2 p.m. on December 12, 1997. Time allotted 
for each presentation may be limited. Those desiring to make formal 
oral presentations should notify the contact person before December 1, 
1997, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 9, 1997.
Michael A. Friedman,
Deputy Commissioner for Operations.
[FR Doc. 97-27531 Filed 10-16-97; 8:45 am]
BILLING CODE 4160-01-F
EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
1350
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection
with the Annual Report of MTM Technologies, Inc. (the Company) on Form 10-K
for the fiscal year ended March 31, 2007, as filed with the Securities and
Exchange Commission on the date hereof (the Report), I, J.W. Braukman III,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

|    |                                                                                                                                                         
|--- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|(1) | The Report
  fully complies with the requirements of Section 13(a) or 15(d) of the
  Securities Exchange Act of 1934; and                               
|    |                                                                                                                                                         
|(2) | The
  information contained in the Report fairly presents, in all material
  respects, the financial condition and results of operations of the Company.

|                      |                          
|--------------------- | -------------------------
|Date: June
  29, 2007 | /s/ J.W.
  Braukman III  
|                      |                          
|                      | J.W.
  Braukman III      
|                      | Chief
  Financial Officer

---